Clementia Pharmaceuticals, Inc.
(UNKNOWN : CMTA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.02%141.880.7%$1091.55m
PFEPfizer Inc.
0.40%43.670.9%$889.76m
MRKMerck & Co., Inc.
-1.14%84.390.6%$745.68m
BMYBristol-Myers Squibb Company
0.60%48.901.4%$532.04m
LLYEli Lilly and Company
0.31%115.591.0%$485.23m
ABBVAbbVie, Inc.
1.36%78.672.2%$356.64m
NVSNovartis AG Sponsored ADR
0.53%92.400.2%$199.01m
AZNAstraZeneca PLC Sponsored ADR
0.20%41.771.2%$117.64m
GSKGlaxoSmithKline plc Sponsored ADR
-0.83%40.660.2%$89.24m
SNYSanofi Sponsored ADR
-0.16%44.010.2%$87.02m
NVONovo Nordisk A/S Sponsored ADR Class B
-2.48%51.120.1%$77.03m
LCILannett Company, Inc.
0.00%5.6836.6%$4.60m
AKTXAkari Therapeutics Plc Sponsored ADR
-5.02%2.081.6%$0.42m
EPIXESSA Pharma Inc
3.27%2.380.1%$0.01m

Company Profile

Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada.